← Back to Search

Afternoon vs Morning Exercise for Prediabetes (TIMED Trial)

N/A
Recruiting
Led By Denis P. Blondin, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pre-diabetes: Fasting plasma glucose: 6.1 to 6.9 mmol/L or 2-hour plasma glucose post 75g OGTT: 7.8 to 11.0 mmol/L and HbA1c: 6.0 to 6.4% or Insulin resistant: glucose clearance rate ≤ 360 ml/kg/min as determined using the Oral Glucose Insulin Sensitivity Index at Time 120 min.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured continuously 2-3 days before and 2-3 days after first and final exercise session, after 12-week exercise intervention.
Awards & highlights

TIMED Trial Summary

This trial is testing whether afternoon exercise is more effective than morning exercise in improving 24-hour blood glucose levels in men with prediabetes.

Who is the study for?
This trial is for men and women with prediabetes, defined by specific blood sugar levels or insulin resistance. Participants must have a BMI over 25, be able to follow the study protocol, and provide informed consent. Exclusions include recent scans, smoking, heavy drinking, certain medical conditions like uncontrolled thyroid disorders or heart disease, and use of medications affecting metabolism.Check my eligibility
What is being tested?
The trial tests whether exercising at different times (morning vs late afternoon) affects blood sugar control in people with prediabetes. It aims to see if timing exercise can improve how the body uses insulin and manages dietary fats in muscles and fat tissue.See study design
What are the potential side effects?
High-intensity interval training generally has few side effects but may include muscle soreness, fatigue after workouts, increased risk of injury if not performed correctly, and possible exacerbation of underlying health issues.

TIMED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have pre-diabetes or insulin resistance based on my blood sugar tests.

TIMED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured continuously 2-3 days before and 2-3 days after first and final exercise session, after 12-week exercise intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured continuously 2-3 days before and 2-3 days after first and final exercise session, after 12-week exercise intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Adipose tissue dietary fatty acid (DFA) partitioning
Change in glucose control.
Change in lean organ (heart, liver, skeletal muscle) DFA partitioning
+1 more
Secondary outcome measures
Change in adipose tissue nonesterified fatty acid (NEFA) metabolism.
Change in composition and activation status of immune cell subsets
Change in dietary fatty acid oxidation
+8 more

TIMED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Afternoon exerciseExperimental Treatment1 Intervention
Participant to perform high-intensity interval training in the morning (~4 pm)
Group II: Morning exerciseActive Control1 Intervention
Participant to perform high-intensity interval training in the morning (~9 am)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-intensity interval training
2016
Completed Phase 4
~1160

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,393 Total Patients Enrolled
Laval UniversityOTHER
417 Previous Clinical Trials
172,224 Total Patients Enrolled
Wageningen UniversityOTHER
170 Previous Clinical Trials
43,776 Total Patients Enrolled

Media Library

High-intensity interval training Clinical Trial Eligibility Overview. Trial Name: NCT05123963 — N/A
Prediabetes Research Study Groups: Morning exercise, Afternoon exercise
Prediabetes Clinical Trial 2023: High-intensity interval training Highlights & Side Effects. Trial Name: NCT05123963 — N/A
High-intensity interval training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05123963 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I fulfill the criteria to be included in this research project?

"This medical trial seeks 48 subjects of pre-diabetic condition aged between 45 and 75 years old. Applicants must meet the following criteria: Fasting plasma glucose range 6.1 to 6.9 mmol/L, 2-hour post OGTT levels of 7.8 to 11.0 mmol/L, HbA1c scores from 6.0 to 6.4%, insulin sensitivity as measured by Oral Glucose Insulin Sensitivity Index < 360 ml/kg/min at Time 120 min., BMI > 25 kg/m2 . Additionally, candidates are expected to willingly adhere to study requirements outlined in a signed informed"

Answered by AI

Are the participants of this experiment limited to people under 60 years old?

"This study is enrolling participants over the age of 45 and under 75 years old."

Answered by AI

Are there still opportunities to sign up for this trial?

"According to clinicaltrials.gov, this medical investigation is currently enrolling patients who meet the inclusion criteria. The trial was first published on September 15th 2021 and was last refreshed on November 17th 2021."

Answered by AI

What is the aggregate amount of individuals involved in this experiment?

"Indeed, the data available on clinicaltrials.gov shows that this experiment is presently recruiting patients. It was first posted online on September 15th 2021 and last edited a few weeks ago on November 17th 2021, with a goal of enrolling 48 subjects from 1 centre."

Answered by AI

What is the principle objective of this research?

"This clinical trial, lasting 170 minutes prior and 30 minutes following a liquid meal at the baseline visit, 18-24 hours after an acute exercise session and >48hours after the final exercise bout (after 12 week intervention) will assess changes in adipose tissue dietary fatty acid partitioning. Assessments of postprandial plasma glucose turnover ([1-3H]-glucose), lean organ NEFA metabolism ([11C]-palmitate/PET acquisition), and postprandial plasma NEFA turnover ([7,7,8,8-2H]-palmitate) are also part of this study's secondary outcome"

Answered by AI
~10 spots leftby Dec 2024